Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
Plaintiff: Novo Nordisk A/S
Defendant: Mylan Pharmaceuticals Inc.
Counter Defendant: Novo Nordisk Inc.
Case Number: 1:2022cv01040
Filed: August 8, 2022
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on September 27, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
September 27, 2022 Filing 46 NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-162) Directed to Defendant Mylan Pharmaceuticals, Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
September 9, 2022 Filing 45 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
September 7, 2022 Pro Hac Vice Attorney Bryan D. Beel for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
September 7, 2022 Pro Hac Vice Attorney Shannon M. Bloodworth for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
August 30, 2022 Opinion or Order SO ORDERED, re (17 in 1:22-md-03038-CFC, 44 in 1:22-cv-01040-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jonathan I. Tietz, Shannon M. Bloodworth, Emily J. Greb, Michael R. Laing, and Bryan D. Beel, Ph.D., filed by Mylan Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 8/30/2022. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd)
August 29, 2022 Filing 44 MOTION for Pro Hac Vice Appearance of Attorney Jonathan I. Tietz, Shannon M. Bloodworth, Emily J. Greb, Michael R. Laing, and Bryan D. Beel, Ph.D. - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
August 26, 2022 Filing 43 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
August 26, 2022 Filing 42 NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Preliminary Disclosure of Asserted Patents and Claims filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian)
August 25, 2022 Filing 41 NOTICE of Appearance by Richard Charles Weinblatt on behalf of Mylan Pharmaceuticals Inc. (Weinblatt, Richard)
August 25, 2022 Filing 40 NOTICE of Appearance by Stamatios Stamoulis on behalf of Mylan Pharmaceuticals Inc. (Stamoulis, Stamatios)
August 22, 2022 Filing 39 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian)
August 22, 2022 Opinion or Order SO ORDERED, re (39 in 1:22-cv-01040-CFC, 11 in 1:22-md-03038-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 8/22/2022. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd)
August 12, 2022 Filing 38 NOTICE OF SERVICE of Plaintiffs' Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
August 10, 2022 Filing 37 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
August 8, 2022 Filing 36 NOTICE of Appearance by Brian P. Egan on behalf of Novo Nordisk A/S, Novo Nordisk Inc. (Egan, Brian)
August 8, 2022 Filing 35 Record of case transferred in from District of West Virginia Northern; Case Number in Other District: 1:22-cv-00023. Copy of Docket Sheet and original file
August 8, 2022 NOTICE TO COUNSEL: MDL No. 1:2022-md-3038 has been opened and assigned to the Honorable Colm F. Connolly. Attorneys of record who will be electronically filing documents may request E-Filing rights through PACER and add the MDL case number in the comments section of your request. Please see the docket for further entries. (smg)
August 8, 2022 NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. (smg)
August 5, 2022 Opinion or Order Filing 34 CERTIFIED COPY OF JPML CONDITIONAL TRANSFER ORDER re: pldg. ( #1 in MDL No. 3038) Transferring 1 action(s) to Judge Colm F. Connolly in the D. Delaware. Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 8/5/2022. Associated Cases: MDL No. 3038, DE/1:22-cv-00294, DE/1:22-cv-00296, DE/1:22-cv-00297, DE/1:22-cv-00298, DE/1:22-cv-00299, WVN/1:22-cv-00023. (jmm) [Transferred from West Virginia Northern on 8/8/2022.]
August 5, 2022 Case transferred to the District of Delaware re MDL 3038. Entire Case file electronically transmitted. (jmm) [Transferred from West Virginia Northern on 8/8/2022.]
May 24, 2022 Opinion or Order Filing 33 ORDER granting #29 Motion of Olivia L. Wheeling for Leave to Appear Pro Hac Vice on behalf of Novo Nordisk, A/S, Novo Nordisk, Inc. Signed by District Judge John Preston Bailey on 5/24/2022. (dk) [Transferred from West Virginia Northern on 8/8/2022.]
May 24, 2022 Opinion or Order Filing 32 ORDER granting #28 Motion of Erica Sutter for Leave to Appear Pro Hac Vice on behalf of Novo Nordisk, A/S, Novo Nordisk, Inc. Signed by District Judge John Preston Bailey on 5/24/2022. (dk) [Transferred from West Virginia Northern on 8/8/2022.]
May 24, 2022 Filing 31 Pro Hac Vice Filing fee for E. Sutter and O. Wheeling: $ 400.00, receipt number WVNC003450. (kam) [Transferred from West Virginia Northern on 8/8/2022.]
May 24, 2022 Filing 30 CERTIFICATE OF SERVICE by Novo Nordisk, A/S Plaintiffs' Disclosure Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure (Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
May 19, 2022 Filing 29 MOTION for Leave to Appear Pro Hac Vice of Olivia L. Wheeling by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
May 19, 2022 Filing 28 MOTION for Leave to Appear Pro Hac Vice of Erica R. Sutter by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Attachment Continued page for Application for Admission, #2 Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
May 16, 2022 Filing 27 REPORT of Rule 26(f) Planning Meeting. (White, Brandon) [Transferred from West Virginia Northern on 8/8/2022.]
May 11, 2022 Filing 26 NOTICE of Appearance by Gordon H. Copland on behalf of Mylan Pharmaceuticals, Inc. (Copland, Gordon) [Transferred from West Virginia Northern on 8/8/2022.]
May 11, 2022 Filing 25 Courtesy copy of Corrected Schedule of Actions and Proof of Service Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Exhibit 1 to Corrected Schedule of Actions, #2 Exhibit 2 to Corrected Schedule of Actions, #3 Exhibit 3 to Corrected Schedule of Actions, #4 Exhibit 4 to Corrected Schedule of Actions, #5 Exhibit 5 to Corrected Schedule of Actions, #6 Exhibit 6 to Corrected Schedule of Actions, #7 Attachment Corrected Proof of Service)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
May 9, 2022 Opinion or Order Filing 24 ORDER EXTENDING DEADLINE re #23 . The Court hereby ORDERS that the parties may submit their Joint Report of Initial Planning Meeting through and until May 16, 2022. Signed by District Judge John Preston Bailey on 5/9/2022. (dk) [Transferred from West Virginia Northern on 8/8/2022.]
May 9, 2022 Filing 23 Joint MOTION for Extension of Deadline to File the Joint Report of Initial Planning Meeting by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
May 6, 2022 Filing 22 Courtesy copy of Motion to Transfer Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Attachment Opening Brief to Motion to Transfer, #2 Attachment Schedule of Actions, #3 Exhibit 1 to Schedule of Actions, #4 Exhibit 2 to Schedule of Actions, #5 Exhibit 3 to Schedule of Actions, #6 Exhibit 4 to Schedule of Actions, #7 Exhibit 5 to Schedule of Actions, #8 Exhibit 6 to Schedule of Actions, #9 Attachment Proof of Service, #10 Attachment Oral Argument Statement)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
April 29, 2022 Filing 21 PLAINTIFFS' ANSWER to #19 Answer to Complaint, Counterclaim by Novo Nordisk, A/S, Novo Nordisk, Inc..(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
April 8, 2022 Filing 20 Corporate Disclosure Statement by Mylan Pharmaceuticals, Inc.. (White, Brandon) [Transferred from West Virginia Northern on 8/8/2022.]
April 8, 2022 Filing 19 ANSWER to #2 Complaint,, , COUNTERCLAIM against All Plaintiffs by Mylan Pharmaceuticals, Inc..(White, Brandon) [Transferred from West Virginia Northern on 8/8/2022.]
March 29, 2022 Opinion or Order Filing 18 ORDER granting #12 Motion for Leave to Appear Pro Hac Vice of Ryan Johnson. Signed by District Judge John Preston Bailey on 03/29/2022. (kam) [Transferred from West Virginia Northern on 8/8/2022.]
March 29, 2022 Opinion or Order Filing 17 ORDER granting #11 Motion for Leave to Appear Pro Hac Vice of Jeffrey Oelke. Signed by District Judge John Preston Bailey on 03/29/2022. (kam) [Transferred from West Virginia Northern on 8/8/2022.]
March 29, 2022 Opinion or Order Filing 16 ORDER granting #10 Motion for Leave to Appear Pro Hac Vice of Robert Counihan. Signed by District Judge John Preston Bailey on 03/29/2022. (kam) [Transferred from West Virginia Northern on 8/8/2022.]
March 29, 2022 Opinion or Order Filing 15 ORDER granting #9 Motion for Leave to Appear Pro Hac Vice of Laura Moran. Signed by District Judge John Preston Bailey on 03/29/2022. (kam) [Transferred from West Virginia Northern on 8/8/2022.]
March 28, 2022 Filing 14 Pro Hac Vice filing fee: $ 800.00, receipt number WVNC003403 as to attorneys L. Morgan, R. Johnson, J. Oelke, and R. Counihan. (kam) [Transferred from West Virginia Northern on 8/8/2022.]
March 28, 2022 Filing 13 WAIVER OF SERVICE Returned Executed by Novo Nordisk, A/S, Novo Nordisk, Inc.. Mylan Pharmaceuticals, Inc. waiver sent on 3/24/2022, answer due 5/23/2022. (Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
March 28, 2022 Filing 12 MOTION for Leave to Appear Pro Hac Vice of Ryan Johnson by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
March 28, 2022 Filing 11 MOTION for Leave to Appear Pro Hac Vice of Jeffrey Oelke by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
March 28, 2022 Filing 10 MOTION for Leave to Appear Pro Hac Vice of Robert Counihan by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
March 28, 2022 Filing 9 MOTION for Leave to Appear Pro Hac Vice of Laura Moran by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Attachments: #1 Proposed Order)(Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
March 28, 2022 Opinion or Order Filing 8 FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 4/25/2022. Rule 26 Meeting Report due by 5/9/2022. Discovery due by 5/23/2022. Signed by District Judge John Preston Bailey on 3/28/2022. (dk) [Transferred from West Virginia Northern on 8/8/2022.]
March 25, 2022 Opinion or Order Filing 7 ORDER. Case reassigned to District Judge John Preston Bailey for all further proceedings. Senior Judge Irene M. Keeley no longer assigned to case. Signed by Senior Judge Irene M. Keeley on 03/25/2022. (kam) [Transferred from West Virginia Northern on 8/8/2022.]
March 18, 2022 Filing 6 Supplemental ANDA Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
March 18, 2022 Filing 5 Disclosure Statement Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]
March 18, 2022 Filing 4 VERIFICATION OF ATTORNEY ADMISSION to Attorneys J. Oelke, L. Moran, R. Johnson, and R. Counihan. (to Oelke, Moran, and Johnson by NEF; to R. Counihan by U.S. mail) (dk) [Transferred from West Virginia Northern on 8/8/2022.]
March 18, 2022 Filing 3 REPORT to USPTO on the filing or determination of an action regarding re #2 Complaint. (dk) [Transferred from West Virginia Northern on 8/8/2022.]
March 18, 2022 Filing 2 COMPLAINT against Mylan Pharmaceuticals, Inc., filed by Novo Nordisk, A/S, Novo Nordisk, Inc. Filing Fee Paid $402. Receipt #AWVNDC-3445410. (Attachments: #1 Exhibit A - 833 Patent, #2 Exhibit B - 343 Patent, #3 Exhibit C - 122 Patent, #4 Exhibit D - 969 Patent, #5 Exhibit E - 383 Patent, #6 Exhibit F - 002 Patent, #7 Exhibit G - 239 Patent, #8 Exhibit H - 154 Patent, #9 Exhibit I - 180 Patent, #10 Exhibit J - 611 Patent, #11 Exhibit K - 953 Patent, #12 Exhibit L - 757 Patent, #13 Exhibit M - 155 Patent, #14 Exhibit N - 462 Patent, #15 Exhibit O - 616 Patent, #16 Exhibit P - 652 Patent, #17 Exhibit Q - 063 Patent, #18 Exhibit R - 363 Patent, #19 Civil Cover Sheet)(dk) [Transferred from West Virginia Northern on 8/8/2022.]
March 18, 2022 Filing 1 REPORT ON FILING ACTION RE PATENT Other Document filed by Novo Nordisk, A/S, Novo Nordisk, Inc.. (Companion, James) [Transferred from West Virginia Northern on 8/8/2022.]

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Novo Nordisk Inc.
Represented By: Erica R. Sutter
Represented By: James F. Companion
Represented By: Jeffrey J. Oelke
Represented By: Olivia L. Wheeling
Represented By: Robert E. Counihan
Represented By: Ryan P. Johnson
Represented By: Sandra K. Law
Represented By: Travis J Murray
Represented By: Laura T. Moran
Represented By: Brian P. Egan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk A/S
Represented By: Erica R. Sutter
Represented By: James F. Companion
Represented By: Jeffrey J. Oelke
Represented By: Olivia L. Wheeling
Represented By: Robert E. Counihan
Represented By: Ryan P. Johnson
Represented By: Sandra K. Law
Represented By: Travis J Murray
Represented By: Laura T. Moran
Represented By: Brian P. Egan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals Inc.
Represented By: Brandon M. White
Represented By: Gordon H. Copland
Represented By: William J O'Brien
Represented By: Bryan D. Beel
Represented By: Richard Charles Weinblatt
Represented By: Shannon M. Bloodworth
Represented By: Stamatios Stamoulis
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?